Today: 9 April 2026
SLB stock price swings after earnings beat: $4B return plan and Venezuela ramp in focus
24 January 2026
2 mins read

SLB stock price swings after earnings beat: $4B return plan and Venezuela ramp in focus

New York, Jan 23, 2026, 18:38 EST — After-hours

  • SLB shares fell roughly 0.3% despite the oilfield services company surpassing quarterly profit estimates and raising its dividend.
  • Management warned of a weaker first quarter but noted it could ramp up operations in Venezuela rapidly if licenses and payments come through.
  • Next week, traders will focus on oil prices, policy signals from Venezuela, and U.S. drilling data.

SLB shares slipped 0.3% to $49.15 on Friday following a volatile session that saw the stock fluctuate between $48.65 and $51.66. Investors digested a quarterly profit beat but remained wary about the near-term outlook.

The oilfield services company emphasized shareholder returns and the potential reopening in Venezuela, though it cautioned that the first quarter may begin on a weaker note. Traders are left wondering if a cash-rich narrative can endure amid uneven drilling and completion activity.

Oil prices pushed higher again, with Brent up 0.7% at $64.49 a barrel and U.S. WTI also climbing 0.7% to $59.78. The moves came amid renewed supply concerns linked to escalating U.S.-Iran tensions. Reuters

SLB reported fourth-quarter revenue of $9.745 billion and adjusted earnings of 78 cents a share in its earnings release. The company said free cash flow — the cash remaining after capital expenditures — hit $2.29 billion. It announced a 3.5% boost to its quarterly dividend, raising it to 29.5 cents per share, payable April 2 to shareholders of record on Feb. 11. SLB also forecast returning over $4 billion to shareholders in 2026. CEO Olivier Le Peuch described the results as “very strong fourth-quarter results.” SEC

The quarter was driven by Production Systems and Digital, with ChampionX playing a larger role following last year’s acquisition. SLB has been pushing harder into production and recovery services — covering chemicals, artificial lift, and subsea gear — as operators look to boost output from existing fields.

SLB said on its post-earnings call that North America land activity is set to keep falling year over year. It expects first-quarter revenue to drop by high-single digits compared to the fourth quarter, with adjusted core profit down 15% to 20%. The company also projected 2026 revenue between $36.9 billion and $37.7 billion, assuming oil prices hold between $50 and the low $60s per barrel. This follows ChampionX contributing $879 million in revenue during the quarter. Reuters

Venezuela remains the wild card. Le Peuch noted, “We are already receiving a lot of inquiries from our customers,” but emphasized SLB will require proper licensing and payment terms before ramping up operations there. Reuters

SLB stands as the sole international oilfield services company currently active in Venezuela, offering services to Chevron under its license, Reuters reports. Halliburton has indicated plans to return once commercial and legal conditions are finalized.

Service demand still hinges largely on drilling activity. The U.S. oil and gas rig count ticked up by one to 544 this week, according to Baker Hughes, but it’s still 32 rigs shy of where it stood a year ago. Reuters

But risks lurk. A steep fall in oil prices would quickly freeze budgets. Venezuela projects might hit a wall over licenses or payment doubts. Plus, SLB’s own forecast points to a first-quarter decline even without fresh disruptions.

When U.S. markets reopen Monday, eyes will be on whether SLB can stay close to $50. The spotlight is shifting from the initial earnings beat to cash returns and the expected first-quarter low. Traders will also be scanning for clear updates from Washington on Venezuela licenses.

Baker Hughes will release its rig count update on Jan. 30 at 13:00 ET — a weekly snapshot the oilfield services sector still leans on to gauge demand. investing.com

Stock Market Today

  • AbbVie's Humira Launch on TrumpRx with 86% Discount Sparks Valuation Questions
    April 9, 2026, 9:02 AM EDT. AbbVie (NYSE:ABBV) has introduced Humira on the TrumpRx platform at an 86% discount under a White House pricing deal aiming to reduce patient costs and widen drug access. This marks a significant US pricing strategy shift post exclusivity for Humira, a key immunology therapy driving substantial revenue. The stock trades near $206.69, about 20% below analyst targets and 43.8% under fair value estimates. The deep discount could alter patient volume, payer ties, and pricing benchmarks in government-linked drug programs. AbbVie's revenue exposure of $61.2 billion and a high price-to-earnings ratio of 87.3 place focus on potential impacts to cash flow and dividends amid its debt load. Investors should monitor reactions from payers, competitors, and capital markets to this pricing shift that could redefine AbbVie's US market dynamics.

Latest article

When Will Gas Prices Fall? Iran Ceasefire May Not Bring Quick Relief as Oil Rebounds

When Will Gas Prices Fall? Iran Ceasefire May Not Bring Quick Relief as Oil Rebounds

9 April 2026
Brent crude rebounded 3% Thursday despite a U.S.-Iran ceasefire, with the Strait of Hormuz still nearly shut and only one oil-products tanker passing in 24 hours. U.S. gasoline averaged $4.166 a gallon on April 9, and AAA said prices could drop slowly. North Sea Forties crude hit a record $146.43 a barrel. The U.S. EIA expects Hormuz flows may take months to recover.
CoreWeave Stock Climbs on $21 Billion Meta AI Cloud Deal, but Debt Risks Stay in Focus

CoreWeave Stock Climbs on $21 Billion Meta AI Cloud Deal, but Debt Risks Stay in Focus

9 April 2026
CoreWeave said Meta Platforms committed about $21 billion for AI cloud capacity through December 2032. Shares rose 4.3% to $88.90 in premarket trading after the announcement. The deal follows an $8.5 billion loan facility and a $1.25 billion senior notes offering. CoreWeave reported $5.13 billion in 2025 revenue and ended December with a $66.8 billion backlog.
NVIDIA’s Rubin AI Chip Ramp Hits Fresh Snag as HBM4 Memory Crunch Clouds 2026

NVIDIA’s Rubin AI Chip Ramp Hits Fresh Snag as HBM4 Memory Crunch Clouds 2026

9 April 2026
TrendForce said April 8 that Nvidia’s Rubin AI chip shipments may be delayed by HBM4 memory qualification and cooling demands, shifting over 70% of 2026 high-end GPU volume to the current Blackwell line. Rubin’s projected share dropped to 22%. Samsung began shipping HBM4 to Nvidia in February, but SK Hynix and Micron face qualification delays. Broadcom signed a long-term deal to develop Google’s TPUs through 2031.
Eli Lilly stock slips after hours as obesity-pill race stays in the spotlight
Previous Story

Eli Lilly stock slips after hours as obesity-pill race stays in the spotlight

ServiceNow stock jumps 3.5% — analysts trim targets ahead of Jan. 28 earnings
Next Story

ServiceNow stock jumps 3.5% — analysts trim targets ahead of Jan. 28 earnings

Go toTop